Cargando…
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
PURPOSE: To establish in vitro and in silico models that predict clinical drug–drug interactions (DDIs) with the OATP1B1 (SLCO1B1) transporter. METHODS: The inhibitory effect of 146 drugs and drug-like compounds on OATP1B1-mediated transport was studied in HEK293 cells. A computational model was dev...
Autores principales: | Karlgren, Maria, Ahlin, Gustav, Bergström, Christel A. S., Svensson, Richard, Palm, Johan, Artursson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264873/ https://www.ncbi.nlm.nih.gov/pubmed/21861202 http://dx.doi.org/10.1007/s11095-011-0564-9 |
Ejemplares similares
-
Classification of Inhibitors
of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence
of Protein Expression on Drug–Drug Interactions
por: Karlgren, Maria, et al.
Publicado: (2012) -
Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
por: Garrison, Dominique A., et al.
Publicado: (2020) -
Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug–Drug Interactions
por: Antonescu, Irina E., et al.
Publicado: (2020) -
Structure of human drug transporters OATP1B1 and OATP1B3
por: Ciută, Anca-Denise, et al.
Publicado: (2023) -
Intracellular drug bioavailability: a new predictor of system dependent drug disposition
por: Mateus, André, et al.
Publicado: (2017)